OncoResponse
Pre-clinicalOur Mission: Attack cancer based on clues offered by the immune systems of Elite Cancer Responders.
Founded
2015
Focus
AntibodiesBiologics
About
Our Mission: Attack cancer based on clues offered by the immune systems of Elite Cancer Responders.
Funding History
2Total raised: $127M
Series B$80MRiverVest Venture PartnersJun 15, 2022
Series A$47MRiverVest Venture PartnersOct 15, 2020
Company Info
TypePrivate
Founded2015
LocationSeattle, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile